Can youth be engineered? Global experts challenge aging

A multinational team from France, India, the Philippines, the USA, and leading European research centers provides a sweeping analysis of how regenerative medicine and longevity science are reshaping cosmetic dermatology. Their work summarizes 15 years of progress and highlights a major shift from temporary aesthetic correction toward long-term strategies that restore cellular health. The authors describe how advances in regenerative therapies, mitochondrial biology, epigenetic modulation, immune balance, microbiome research, and AI-driven personalization are redefining the foundations of skin-aging care. 

Regenerative medicine forms a central pillar, with platelet-rich plasma, stem cell–based approaches, and exosome therapies showing the ability to stimulate collagen, repair tissue, and counter cellular senescence. These techniques target biological mechanisms rather than superficial symptoms, offering more durable and clinically meaningful results. Mitochondrial-directed strategies, including NAD+ precursors and targeted antioxidants, are also gaining traction for their potential to improve cellular energy, reduce oxidative stress, and slow visible aging.

Epigenetic interventions—ranging from Yamanaka factors to RNA-based therapeutics—are being explored for their ability to reverse age-related gene expression patterns. The review also explains how immune dysregulation and chronic inflammation accelerate aging, while a stable skin microbiome may enhance resilience and repair.

AI-driven diagnostics and predictive models represent another transformative area, enabling highly personalized longevity plans. The authors caution that rapid innovation must be matched with ethical oversight, equitable access, and strong regulatory safeguards to avoid widening disparities in aesthetic and preventive care.